16.1
Sistemas de Liberação de Fármacos: Diferentes Tipos
Os medicamentos orais convencionais, denominados formulações de liberação imediata, ou IR, são projetados para liberar prontamente seu insumo farmacêu…
Formulações convencionais de liberação imediata liberam o ingrediente ativo imediatamente após a ingestão, levando a uma absorção rápida. No entanto, formulações contendo medicamentos pouco solúveis podem apresentar absorção mais lenta.
Para superar essas limitações, formas de dosagem de liberação modificada foram projetadas para controlar os padrões de liberação de medicamentos. Vários tipos de medicamentos orais de liberação modificada estão disponíveis.
Formulações de liberação prolongada são projetadas para sustentar a liberação do medicamento, manter os níveis terapêuticos por períodos mais longos e reduzir a frequência da dosagem.
Formulações de liberação retardada, muitas vezes com revestimentos entéricos, protegem o medicamento do ambiente ácido do estômago e garantem a liberação apenas nos intestinos, otimizando os perfis de absorção.
Formulações de liberação direcionada administram medicamentos em locais específicos do corpo, maximizando os efeitos terapêuticos e minimizando a exposição sistêmica. Essas formulações podem ser projetadas para liberação imediata ou prolongada de medicamentos.
Comprimidos que se desintegram oralmente se dissolvem rapidamente na saliva, permitindo a absorção direta de medicamentos buccais e efeitos terapêuticos mais rápidos. Eles são ideais para pacientes que têm dificuldade em engolir comprimidos convencionais.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between immediate-release and modified-release drug formulations?
Immediate-release formulations release the active pharmaceutical ingredient promptly upon ingestion, leading to rapid absorption and quick therapeutic effects. Modified-release formulations deliberately alter drug release rate and timing to achieve specific therapeutic goals, maintain consistent drug levels, and improve patient adherence by reducing dosing frequency.
Q2: How do extended-release formulations maintain therapeutic drug levels?
Extended-release formulations utilize advanced technologies such as matrix systems and osmotic pumps to control drug release gradually over extended periods. Matrix systems embed the drug in a dissolving matrix, while osmotic pumps release drug through a semipermeable membrane opening, maintaining steady bloodstream levels and minimizing fluctuations.
Q3: Why are enteric coatings used in delayed-release formulations?
Enteric coatings protect drugs from the acidic stomach environment by resisting stomach acid and ensuring release only in the intestines. This approach optimizes absorption profiles and reduces gastric irritation, exemplified by enteric-coated aspirin, which enhances therapeutic efficacy while mitigating side effects.
Q4: What are the advantages of targeted-release drug delivery systems?
Targeted-release formulations deliver drugs directly to specific physiological sites using advanced carriers like liposomes or nanoparticles, enhancing therapeutic effects while minimizing systemic exposure. This precise delivery and localized action is particularly beneficial in treatments like cancer therapy, reducing unwanted side effects.
Q5: How do orally disintegrating tablets benefit patients with swallowing difficulties?
Orally disintegrating tablets dissolve rapidly in saliva, facilitating quick drug absorption without requiring water. This formulation enables direct buccal drug absorption and quicker therapeutic effects, making them particularly suitable for patients with swallowing difficulties or those unable to take conventional tablets.
Q6: What factors affect drug absorption in immediate-release formulations?
Drug absorption in immediate-release formulations depends on the drug's physicochemical properties. Poorly soluble drugs may exhibit slower absorption due to gradual dissolution in the gastrointestinal tract, while prodrugs require metabolic conversion to activate their effects, introducing delays in onset times.
Q7: How do modified-release formulations improve patient adherence?
Modified-release formulations reduce dosing frequency by maintaining therapeutic drug levels over extended periods, allowing patients to take medication less often. This consistent drug delivery minimizes fluctuations in blood concentration, improving treatment outcomes and making medication regimens easier for patients to follow.